vs
Side-by-side financial comparison of ECARX Holdings Inc. (ECX) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
ECARX Holdings Inc. is the larger business by last-quarter revenue ($323.3M vs $250.2M, roughly 1.3× USANA HEALTH SCIENCES INC). USANA HEALTH SCIENCES INC runs the higher net margin — 3.0% vs -21.4%, a 24.4% gap on every dollar of revenue. On growth, ECARX Holdings Inc. posted the faster year-over-year revenue change (6.5% vs -3.0%).
ECARX Holdings Inc. is a global mobility technology provider specializing in integrated smart vehicle solutions, including in-vehicle infotainment systems, advanced driver assistance technologies, and connected car cloud services. It primarily partners with automotive manufacturers across the world, with a strong operational presence in the Chinese and European markets.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
ECX vs USNA — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $323.3M | $250.2M |
| Net Profit | $-69.1M | $7.5M |
| Gross Margin | 15.5% | 76.2% |
| Operating Margin | -20.2% | 5.5% |
| Net Margin | -21.4% | 3.0% |
| Revenue YoY | 6.5% | -3.0% |
| Net Profit YoY | 12.8% | -20.0% |
| EPS (diluted) | $-0.20 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | — | $226.2M | ||
| Q3 25 | — | $213.7M | ||
| Q2 25 | $323.3M | $235.8M | ||
| Q1 25 | — | $249.5M | ||
| Q4 24 | — | $213.6M | ||
| Q3 24 | — | $200.2M | ||
| Q2 24 | $303.5M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | — | $180.0K | ||
| Q3 25 | — | $-6.5M | ||
| Q2 25 | $-69.1M | $9.7M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | $-79.2M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | 15.5% | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | 22.6% | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | -20.2% | 7.1% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | -22.2% | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | -3.1% | ||
| Q2 25 | -21.4% | 4.1% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | -26.1% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | — | $-0.10 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | $-0.20 | $0.52 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $0.56 | ||
| Q2 24 | $-0.23 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.2M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-293.7M | — |
| Total Assets | $494.9M | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | — | $158.4M | ||
| Q3 25 | — | $145.3M | ||
| Q2 25 | $86.2M | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | — | $364.9M | ||
| Q2 24 | $108.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $528.1M | ||
| Q2 25 | $-293.7M | $531.1M | ||
| Q1 25 | — | $529.8M | ||
| Q4 24 | — | $532.1M | ||
| Q3 24 | — | $533.1M | ||
| Q2 24 | $-198.5M | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | — | $742.9M | ||
| Q3 25 | — | $726.6M | ||
| Q2 25 | $494.9M | $734.5M | ||
| Q1 25 | — | $746.6M | ||
| Q4 24 | — | $748.2M | ||
| Q3 24 | — | $671.3M | ||
| Q2 24 | $555.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-82.0M | — |
| Free Cash FlowOCF − Capex | $-86.5M | — |
| FCF MarginFCF / Revenue | -26.7% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $-2.0M | ||
| Q2 25 | $-82.0M | $12.2M | ||
| Q1 25 | — | $15.5M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | — | $29.5M | ||
| Q2 24 | $-57.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $-5.2M | ||
| Q2 25 | $-86.5M | $7.2M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M | ||
| Q2 24 | $-64.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | -26.7% | 3.0% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | -21.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | 1.4% | 2.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | 2.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
